BLL Peptides BPC-157 is USA-manufactured and produced to pharmaceutical-grade standards with 98% purity verified by HPLC testing
Portacolone E, Palmer NR, Lichtenberg P, et al
Frequency 12 daily, subcutaneous commonly placed near the site of interest in research models
As early adopters and long-time researchers deeply fascinated by the potential of peptides, we spent years navigating an industry that often felt like the Wild West
Management of ME/CFS As well as there being insufficient diagnostic testing available for ME/CFS patients, there are also no effective therapies (60, 488, 529531) and few established non-pharmacological treatments for ME/CFS (60), paucity of diagnostic tools (60), heterogeneity between patients (60, 529), disbelief from health care workers (60), unpredictable relapses, and multiplicity of symptoms have made it difficult to formulate a treatment for ME/CFS
AOD-9604 isn't available as a standard commercial medication